Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The cytoprotective protein C pathway.

Mosnier LO, Zlokovic BV, Griffin JH.

Blood. 2007 Apr 15;109(8):3161-72. Epub 2006 Nov 16. Review.

2.

Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities.

Mosnier LO, Griffin JH.

Front Biosci. 2006 Sep 1;11:2381-99. Review.

PMID:
16720321
3.

Activated protein C and ischemic stroke.

Griffin JH, Fernández JA, Liu D, Cheng T, Guo H, Zlokovic BV.

Crit Care Med. 2004 May;32(5 Suppl):S247-53. Review.

PMID:
15118526
4.

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.

Esmon CT.

Crit Care Med. 2001 Jul;29(7 Suppl):S48-51; discussion 51-2. Review.

PMID:
11445734
5.
6.

Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.

Dahlbäck B, Villoutreix BO.

Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1311-20. Epub 2005 Apr 28. Review.

7.

Endogenous protein C activation in patients with severe sepsis.

Liaw PC.

Crit Care Med. 2004 May;32(5 Suppl):S214-8. Review.

PMID:
15118520
8.

The anticoagulant protein C pathway.

Dahlbäck B, Villoutreix BO.

FEBS Lett. 2005 Jun 13;579(15):3310-6. Epub 2005 Mar 13. Review.

9.

The multifunctional protein C system.

Espana F, Medina P, Navarro S, Zorio E, Estellés A, Aznar J.

Curr Med Chem Cardiovasc Hematol Agents. 2005 Apr;3(2):119-31. Review.

PMID:
15853699
10.

Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke.

Griffin JH, Zlokovic B, Fernández JA.

Semin Hematol. 2002 Jul;39(3):197-205. Review.

PMID:
12124682
11.

2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.

Griffin JH, Mosnier LO, Fernández JA, Zlokovic BV.

Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2143-2151. Epub 2016 Oct 6. Review.

12.

Congenital and acquired activated protein C resistance.

Nicolaes GA, Dahlbäck B.

Semin Vasc Med. 2003 Feb;3(1):33-46. Review.

PMID:
15199491
13.

Factor V Leiden: a disorder of factor V anticoagulant function.

Castoldi E, Rosing J.

Curr Opin Hematol. 2004 May;11(3):176-81. Review.

PMID:
15257017
14.

Activated protein C: biased for translation.

Griffin JH, Zlokovic BV, Mosnier LO.

Blood. 2015 May 7;125(19):2898-907. doi: 10.1182/blood-2015-02-355974. Epub 2015 Mar 30. Review.

15.

Signal transduction induced by activated protein C: no role in protection against sepsis?

Slofstra SH, ten Cate H, Spek CA.

Trends Mol Med. 2006 Aug;12(8):374-81. Epub 2006 Jul 3. Review.

PMID:
16820322
16.
17.

Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway.

Joyce DE, Nelson DR, Grinnell BW.

Crit Care Med. 2004 May;32(5 Suppl):S280-6. Review.

PMID:
15118531
18.

Inflammation and the activated protein C anticoagulant pathway.

Esmon CT.

Semin Thromb Hemost. 2006 Apr;32 Suppl 1:49-60. Review.

PMID:
16673266
19.

Cytoprotective-selective activated protein C therapy for ischaemic stroke.

Mosnier LO, Zlokovic BV, Griffin JH.

Thromb Haemost. 2014 Nov;112(5):883-92. doi: 10.1160/TH14-05-0448. Epub 2014 Sep 18. Review.

20.

The discovery of activated protein C resistance.

Dahlbäck B.

J Thromb Haemost. 2003 Jan;1(1):3-9. Review.

Supplemental Content

Support Center